Correlation between GLP-1 receptor agonist usage and reduced alcohol consumption in the US

A report suggests that the widespread adoption of GLP-1 medications like Ozempic may be contributing to lower violent crime rates by reducing alcohol consumption among users. The causal link remains speculative and lacks definitive clinical consensus, though it highlights potential secondary behavioral impacts of weight-loss drugs.